Diagnostics Pipeline: 2024 Trends in FDA Approvals
In vitro diagnostic products approved by the U.S. Food and Drug Administration in 2024 show a continued move toward rapid and point-of-care tests
Keeps You Up-to-Date on New Diagnostic Tests, Testing Trends and Opportunities, and Emerging Test Technologies
In vitro diagnostic products approved by the U.S. Food and Drug Administration in 2024 show a continued move toward rapid and point-of-care tests
From - Diagnostic Testing & Emerging Technologies
A joint guideline from the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and…
From - Diagnostic Testing & Emerging Technologies
The majority of women are willing to undergo less frequent cervical cancer screening, consistent with screening guidelines, if it was…
From - Diagnostic Testing & Emerging Technologies
Large-scale sequencing initiatives performed in integrated health care systems, such as the DiscovEHR collaboration, can advance genetic discovery and serve as a…